Table 3.
Domain ratings between patient subgroups
| Male | Female | Age < 55 years | Age ≥ 55 years | OA | RA | THR | TKR | |
|---|---|---|---|---|---|---|---|---|
| Core domains | ||||||||
| Joint pain | 8 (7–9) | 9 (8–9) | 9 (7–9) | 9 (8–9) | 9 (8–9) | 9 (7–9) | 9 (8–9) | 9 (7–9) |
| *** | ** | |||||||
| Function | 9 (8–9) | 9 (8–9) | 9 (8–9) | 9 (8–9) | 9 (8–9) | 9 (8–9) | 9 (8–9) | 9 (8–9) |
| *** | * | * | ||||||
| Patient satisfaction | 8 (8–9) | 9 (8–9) | 9 (8–9) | 9 (8–9) | 9 (8–9) | 8 (8–9) | 9 (8–9) | 8 (8–9) |
| *** | *** | |||||||
| Revision surgery | 7 (4–9) | 8 (5–9) | 7 (5–9) | 8 (5–9) | 8 (5–9) | 7 (5–9) | 8 (5–9) | 7 (5–9) |
| *** | ||||||||
| Adverse events | 8 (6–9) | 9 (7–9) | 8 (7–9) | 8 (7–9) | 8 (7–9) | 8 (5–9) | 8 (7–9) | 8 (6–9) |
| *** | ||||||||
| Death | 9 (5–9) | 9 (6–9) | 9 (6–9) | 9 (6–9) | 9 (6–9) | 8 (6–9) | 9 (7–9) | 9 (5–9) |
| *** | * | |||||||
| Additional domains | ||||||||
| Cost | 7 (5–8) | 7 (5–9) | 7 (5–8) | 7 (5–8) | 7 (5–8) | 7 (5–9) | 7 (5–8) | 7 (5–8) |
| *** | * | |||||||
| Patient participation | 7 (6–9) | 8 (7–9) | 8 (6–9) | 8 (6–9) | 8 (6–9) | 8 (7–9) | 8 (6–9) | 8 (6–9) |
| *** | ||||||||
Abbreviations: OA Osteoarthritis, RA Rheumatoid arthritis, THR Total hip replacement, TKR Total knee replacement
Significant p values are denoted as follows: * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001. Blank values underneath each pair of median (IQR) indicate no statistical significance. Each domain was rated on a 1–9 scale, with 1–3 indicating limited or no importance for patients, 4–6 being important but not critical, and 7–9 being critical